From the American Academy of Ophthalmology: Eye Doctors Must Learn to Pay Closer Attention to Depression in Their Patients with Vision Loss

At the Annual Meeting of the American Academy of Ophthalmology (AAO) in New Orleans, Louisiana, November 11-14, 2017, Dr. John D. Shepherd, Director of the Weigel Williamson Center for Visual Rehabilitation at the University of Nebraska Medical Center, delivered a powerful lecture on older adults, depression, and vision loss. Dr. Shepherd discussed his own experience … Continued

November Is Diabetic Eye Disease Awareness Month: Learn More About Diabetes and Your Eyes

November is Diabetic Eye Disease Awareness Month, which aims to increase awareness of diabetes and diabetic eye disease and encourage people with diabetes to seek treatment for vision problems related to diabetes. You can learn more about diabetes at What Is Diabetes? and ¿Qué es la diabetes? at VisionAware. According to Prevent Blindness America, diabetes … Continued

During Healthy Aging Month, Learn More About Older Adult Eye Health and Low Vision from the National Eye Institute

According to the United States National Eye Institute, “Older adults are at higher risk for certain eye diseases and conditions, including age-related macular degeneration, cataract, diabetic eye disease, glaucoma, dry eye, and low vision. Eye diseases often have no early symptoms, but can be detected during a comprehensive dilated eye exam.” “More than 40 million … Continued

A New Eye Health Awareness Program from the National Eye Institute Designed Specifically for African American Consumers: Write the Vision

A growing body of diabetes, vision, and health care research indicates that significant disparities in the quality and equity of eye care exist throughout the United States, specifically within African American patient communities. This research includes evaluating the disparities in screening rates for diabetic retinopathy among minority patients, examining the rates of vision loss of … Continued

The Reality and Costs of Gene Therapy for Eye Disease: Who Will (or Can) Pay?

As our readers know, VisionAware is committed to providing current and reliable information about eye and vision research that is relevant to adults and older adults, many of whom experience late-life vision loss resulting in low vision. During the past several years, gene therapy has gained traction and offers promise for treating (but not yet … Continued

Researchers Continue to Explore the Potential of Human Echolocation and Acoustics for People with Vision Loss

Vision rehabilitation professionals, including Orientation and Mobility Specialists, Vision Rehabilitation Therapists, and Low Vision Therapists, have long been aware of the need to incorporate sensory input, including echolocation, in their instructional programs. Human echolocation describes the ability of humans to detect objects in their environments by sensing reflected sound waves from those objects. Now it … Continued

New Genetic Research in Diabetes Identifies a Protein That May Stop or Reduce Abnormal Blood Vessel Growth in the Retina

New genetic research in diabetes, led by a team from Harvard Medical School, has identified a potential new therapy targeting RUNX1 (explained below) that significantly reduced abnormal blood vessel growth in the retina, which is a hallmark of advanced diabetic eye disease. Although the research has been conducted only with “in vitro” (explained below) laboratory … Continued

May Is Healthy Vision Month: Make Your Eye Health a Priority and Learn How to Protect Your Vision

May is Healthy Vision Month, a national eye health observance established by the National Eye Institute (NEI) in May 2003. NEI is part of the National Institutes of Health, an agency of the United States Department of Health and Human Services. This year, NEI is encouraging women to make eye health a priority and has … Continued

The FDA Approves Lucentis for the Treatment of Diabetic Retinopathy

On April 17, 2017, the United States Food and Drug Administration (FDA) granted approval to the injectable drug Lucentis (generic name ranibizumab) for the treatment of proliferative diabetic retinopathy (PDR), a serious vision-related complication of diabetes. Previously, the FDA approved Lucentis for the treatment of diabetic macular edema (DME), a buildup of fluid in the … Continued

Do the Brains of Blind Persons “Rewire” or Adjust to Significantly Enhance the Other Senses? New Research Says Yes

An age-old question that surfaces regularly in my work is this one: “Is it true that blind people develop super senses, like extra-sensitive hearing or touch, to compensate for not being able to see?” A variation of the “super senses” question asks this: “Are the other senses truly enhanced, or do people without the sense … Continued